(MedPage Today) -- WASHINGTON, D.C. -- Transcatheter aortic valve implantation (TAVI) with the CoreValve device improved survival compared with surgery in the high-risk pivotal trial cohort. via MedPageToday.com - medical news plus CME for physicians Read More Here..
Lake forest health and fitness http://ift.tt/1dEaAH1
No comments:
Post a Comment